The pharmaceutical industry is in the headlines daily for its record-breaking efforts developing COVID-19 vaccines.  While most press has been very positive, some aspects of this industry have been and still remain a matter of regular debate, especially drug prices. In the name of drug pricing transparency, many state governments have become more active than ever at imposing … Continue reading “The Growing Use of State Government Disclosure and Reporting Requirements for Pharmaceutical Pricing and Costs”